Pharmaceutical Executive, Jan 1, 2012 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Jan 1, 2012
Features
Copay Cards and Coupons: Letting the Facts Get in the Way
By Mason Tenaglia
Mason Tenaglia offers empirical defense of coupons and copay offset programs.
iPad Apps: Are You Content with your Content?
By Julian Upton
Pharma has become unusually quick to strike embrace the iPad. But the industry's inherent conservatism means it has some way to go to fully milk the device's potential.
Compliance: Getting Those Ducks in a Row
By Jennifer Ringler
Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.
Pharma 2012: Hard Times Before the Harvest
By William Looney
The challenge for 2012 is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.
Columns
New Year, New Issues
By Jill Wechsler
Look for action in 2012 on drug access, shortages, innovation, and transparency.
Essential Questions for Essential Benefits
By Christopher J. Piazza
A key consideration under the Affordable Care Act is how states select plans for drug coverage.
Here's to a Happier New Year?
By Reflector
A turbulent year is ahead for European pharma, while EFPIA's Director General begins to rethink its approach to new science.
Top Medical Innovations 2012
By Ben Comer
A selection of the recent breakthrough technologies showcased at the Cleveland Clinic's Medical Innovations Summit.
Innovation: Why is Pharma Scared to Death?
By Bill Drummy
It's a disturbing irony: In an industry whose entire economic value is founded on its ability to innovate, why is there so much discomfort with the risk required for innovation. Where did the courage to innovate go?

ADVERTISEMENT

Click here